Upadacitinib in Autoimmune Enteropathy—A Case Report
Inflammatory Bowel Diseases · 13.06.2025 · 31 (6) · 1743-1745
DOI: 10.1093/ibd/izaf002 ↗Kurz gefasst
Fallbericht in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 14.02.2025. Verfasst von Simone Chin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Austin Health, Melbourne, VIC, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Lay Summary Autoimmune enteropathy (AIE) is a rare condition, which can be debilitating. We report a steroid-refractory case of AIE which responded to upadacitinib.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Austin Health, Melbourne, VIC, Australia.
- Department of Pathology, Austin Health, Melbourne, VIC, Australia.
- Department of Medicine, Austin Academic Centre, The University of Melbourne, Melbourne, VIC, Australia.
ORCID-Profile: Simone Chin, Darren Wong, Peter De Cruz
Zitieren
APA
Chin, S., Lokan, J., Wong, D., De Cruz, P., & Choy, M. (2025). Upadacitinib in Autoimmune Enteropathy—A Case Report. Inflammatory Bowel Diseases, 31(6), 1743-1745. https://doi.org/10.1093/ibd/izaf002
Vancouver
Chin S, Lokan J, Wong D, De Cruz P, Choy M. Upadacitinib in Autoimmune Enteropathy—A Case Report. Inflammatory Bowel Diseases. 2025;31(6):1743-1745. doi:10.1093/ibd/izaf002
BibTeX
@article{Chin2025,
author = {Chin, Simone and Lokan, Julie and Wong, Darren and De Cruz, Peter and Choy, Matthew},
title = {Upadacitinib in Autoimmune Enteropathy—A Case Report},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {6},
pages = {1743--1745},
doi = {10.1093/ibd/izaf002}
}
EUVIMED